Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0001209191-19-023125

Options or other derivatives

  • Director acquired 4,047 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ferrante Karen Jean · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-04-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +4,047 $2.72 $11,002 4,047 D
Loading xslF345X03/doc4.xml…